Thus, the objective of this study was to examine the effect of de-escalated P2Y12 inhibitor switching in DAPT on the major cardiovascular risks in patients with acute myocardial infarction (AMI) undergoing PCI based on real-world data from the Taiwan’s National Health Insurance Research Database (NHIRD). Here, P2RY12 is linked to acute myocardial infarction.